Form 4: Adaptive Biotechnologies Executive Bobulsky Reports Stock Transactions
SEC Form 4
Susan Bobulsky, Chief Commercial Officer, MRD at Adaptive Biotechnologies, reports acquisition and disposal of company stock and stock options related to vesting of RSUs.
Summary
- On March 4, 2025, Susan Bobulsky acquired 119,971 shares of Adaptive Biotechnologies common stock.
- These shares were acquired at a price of $0.
- Also on March 4, 2025, Bobulsky acquired 180,029 stock options with an exercise price of $8.12, vesting in installments starting March 4, 2026.
- On March 5, 2025, Bobulsky sold 26,023 shares of common stock at $6.98 per share.
- The sale was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: Neutral sentiment as the document simply reports stock transactions related to compensation and tax obligations.
Future Outlook
The options vest with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company executive, providing transparency to investors regarding insider activity.
Stakeholder Impact
- Shareholders are informed about executive stock transactions, providing transparency into management's holdings and potential alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Acquisition of 119,971 shares of common stock and 180,029 stock options. |
| 03/05/2025 | Sale of 26,023 shares of common stock at $6.98 per share. |
| 03/06/2025 | Date of Form 4 signature. |
| 03/04/2026 | First vesting date for 1/4 of the acquired stock options. |
| 03/04/2035 | Expiration date of the acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.